Options
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
ISSN
2352-3964
Date Issued
2022
Author(s)
Levin, Johannes
Sing, Nand
Melbourne, Sue
Morgan, Amber
Mariner, Carla
Spillantini, Maria Grazia
Wegrzynowicz, Michal
Dalley, Jeffrey W.
Langer, Simon
Giese, Armin
DOI
10.1016/j.ebiom.2022.104021
